[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sophia Genetics Sa LA PIECE CH-1180 ROLLE V8 00000 CHE

www.sophiagenetics.com Employees: 415 P: 41-21-694-1060

Sector:

Medical

Description:

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 391,973
Enterprise Value, $K 369,413
Shares Outstanding, K 71,790
Float, K 68,287
% Float 95.12%
Short Interest, K 279
Short Float 0.39%
Days to Cover 4.30
Short Volume Ratio 0.22
% of Insider Shareholders 4.88%
% of Institutional Shareholders 31.59%

Financials:

Annual Sales, $ 77,270 K
Annual Net Income, $ -79,000 K
Last Quarter Sales, $ 21,690 K
Last Quarter Net Income, $ -19,320 K
EBIT, $ -72,150 K
EBITDA, $ -62,620 K

Growth:

1-Year Return 79.61%
3-Year Return 42.19%
5-Year Return 0.00%
5-Year Revenue Growth 172.08%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 05/05/26
Next Earnings Date 08/04/26
Earnings Per Share ttm -0.52
EPS Growth vs. Prev Qtr 3.57%
EPS Growth vs. Prev Year -3.85%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SOPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.74%
Return-on-Assets % -21.85%
Profit Margin % -102.24%
Debt/Equity 1.05
Price/Sales 4.87
Price/Cash Flow N/A
Price/Book 8.23
Book Value/Share 0.67
Interest Coverage -16.03
60-Month Beta 0.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.